Search research articles
Contact Us
Filters
Showing results (41-50 of 80) with videos related to
Page
of 8
Sort By:
Annals of the Rheumatic Diseases
|
November 25, 2021
Efficacy and safety of guselkumab in patients with active psoriatic arthritis who are inadequate responders to tumour necrosis factor inhibitors: results through one year of a phase IIIb, randomised, controlled study (COSMOS)
Laura C Coates, Laure Gossec, Elke Theander, et al.
Nature Reviews. Disease Primers
|
July 8, 2016
Sjögren syndrome
Pilar Brito-Zerón, Chiara Baldini, Hendrika Bootsma, et al.
Peptides
|
January 23, 2016
Application of synthetic peptides for detection of anti-citrullinated peptide antibodies
Nicole Hartwig Trier, Bettina Eide Holm, Ole Slot, et al.
Arthritis Care & Research
|
April 15, 2010
Accurate detection of changes in disease activity in primary Sjögren's syndrome by the European League Against Rheumatism Sjögren's Syndrome Disease Activity Index
Raphaèle Seror, Xavier Mariette, Simon Bowman, et al.
Scientific Reports
|
March 1, 2018
Antibodies to a strain-specific citrullinated Epstein-Barr virus peptide diagnoses rheumatoid arthritis
Nicole Hartwig Trier, Bettina Eide Holm, Julie Heiden, et al.
Journal of Autoimmunity
|
February 28, 2012
Outcome measures for primary Sjögren's syndrome
Raphaèle Seror, Hendrika Bootsma, Simon J Bowman, et al.
Journal of Autoimmunity
|
January 14, 2014
Outcome measures for primary Sjögren's syndrome: a comprehensive review
Raphaèle Seror, Elke Theander, Hendrika Bootsma, et al.
Annals of the Rheumatic Diseases
|
April 23, 2013
Genetic associations to germinal centre formation in primary Sjogren's syndrome
Tove Ragna Reksten, Svein Joar Auglænd Johnsen, Malin Viktoria Jonsson, et al.
Annals of the Rheumatic Diseases
|
December 25, 2012
Classification criteria for Sjogren's syndrome: we actually need to definitively resolve the long debate on the issue
Claudio Vitali, Hendrika Bootsma, Simon J Bowman, et al.
RMD Open
|
March 31, 2023
Identification of PsA phenotypes with machine learning analytics using data from two phase III clinical trials of guselkumab in a bio-naïve population of patients with PsA
Pascal Richette, Marijn Vis, Sarah Ohrndorf, et al.
Page
of 8
Search research articles
Search
Showing results (41-50 of 80) with videos related to
Sort By:
Page
of 8
Annals of the Rheumatic Diseases
|
November 25, 2021
Efficacy and safety of guselkumab in patients with active psoriatic arthritis who are inadequate responders to tumour necrosis factor inhibitors: results through one year of a phase IIIb, randomised, controlled study (COSMOS)
Laura C Coates, Laure Gossec, Elke Theander, et al.
Nature Reviews. Disease Primers
|
July 8, 2016
Sjögren syndrome
Pilar Brito-Zerón, Chiara Baldini, Hendrika Bootsma, et al.
Peptides
|
January 23, 2016
Application of synthetic peptides for detection of anti-citrullinated peptide antibodies
Nicole Hartwig Trier, Bettina Eide Holm, Ole Slot, et al.
Arthritis Care & Research
|
April 15, 2010
Accurate detection of changes in disease activity in primary Sjögren's syndrome by the European League Against Rheumatism Sjögren's Syndrome Disease Activity Index
Raphaèle Seror, Xavier Mariette, Simon Bowman, et al.
Scientific Reports
|
March 1, 2018
Antibodies to a strain-specific citrullinated Epstein-Barr virus peptide diagnoses rheumatoid arthritis
Nicole Hartwig Trier, Bettina Eide Holm, Julie Heiden, et al.
Journal of Autoimmunity
|
February 28, 2012
Outcome measures for primary Sjögren's syndrome
Raphaèle Seror, Hendrika Bootsma, Simon J Bowman, et al.
Journal of Autoimmunity
|
January 14, 2014
Outcome measures for primary Sjögren's syndrome: a comprehensive review
Raphaèle Seror, Elke Theander, Hendrika Bootsma, et al.
Annals of the Rheumatic Diseases
|
April 23, 2013
Genetic associations to germinal centre formation in primary Sjogren's syndrome
Tove Ragna Reksten, Svein Joar Auglænd Johnsen, Malin Viktoria Jonsson, et al.
Annals of the Rheumatic Diseases
|
December 25, 2012
Classification criteria for Sjogren's syndrome: we actually need to definitively resolve the long debate on the issue
Claudio Vitali, Hendrika Bootsma, Simon J Bowman, et al.
RMD Open
|
March 31, 2023
Identification of PsA phenotypes with machine learning analytics using data from two phase III clinical trials of guselkumab in a bio-naïve population of patients with PsA
Pascal Richette, Marijn Vis, Sarah Ohrndorf, et al.
Page
of 8